# Genscript Biotech Corporation (GNNSF)

> Healthcare · HK · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/GNNSF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 403.15M | $ -129.00M | N/A | $ 254.62M | $ 3.88B |
| 2025 | $ 983.33M | $ -546.56M | $ 265.47M | $ 609.07M | $ 3.96B |
| 2024 | $ 624.85M | $ 3.11B | $ -75.96M | $ 170.57M | $ 4.32B |
| 2023 | $ 908.27M | $ -103.24M | $ -475.96M | $ 417.74M | $ 1.39B |
| 2022 | $ 699.02M | $ -253.30M | $ -364.04M | $ 349.80M | $ 1.01B |
| 2021 | $ 606.69M | $ -412.86M | $ -325.04M | $ 156.45M | $ 879.75M |
| 2020 | $ 498.10M | $ -261.24M | $ -345.04M | $ 55.00M | $ 901.71M |
| 2019 | $ 354.34M | $ -125.64M | $ -192.32M | $ 24.13M | $ 382.80M |
| 2018 | $ 305.10M | $ 28.02M | $ 312.77M | $ 10.50M | $ 478.66M |
| 2017 | $ 205.64M | $ 35.19M | $ -10.57M | $ 0 | $ 217.81M |
| 2016 | $ 157.86M | $ 36.01M | $ 34.01M | $ 0 | $ 177.61M |
| 2015 | $ 121.74M | $ 24.58M | $ 18.15M | $ 0 | $ 149.25M |
| 2014 | $ 98.90M | $ 8.73M | $ 6.85M | $ 8.17M | $ 61.71M |
| 2013 | $ 85.48M | $ 8.53M | $ 5.13M | $ 7.39M | $ 52.53M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.07 |
| Liabilities / Eq | 0.23 |
| Current Ratio | 1.48 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 1.87 |

## Other views

- [Metrics](https://sponda.capital/en/GNNSF.md)
- [Charts](https://sponda.capital/en/GNNSF/charts.md)
- [Compare](https://sponda.capital/en/GNNSF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.